Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lupin Pharmaceuticals Issues Voluntary Recall of Ceftriaxone for Injection

americanpharmaceuticalreviewJanuary 10, 2019

Tag: Injection , Lupin Pharmaceuticals , ceftriaxone , vein irritation

PharmaSources Customer Service